Jiangsu Lingyun Pharmaceutical Co., Ltd. was founded in 2000, is a professional engaged in the international new raw materials (chemical synthetic drugs and biological fermentation semi-synthetic drugs) research and development, manufacturing, sales, service and other integration of national high-tech enterprises. Company registered capital of 36.94 million yuan, 200 million yuan of fixed assets. The headquarters and R & D base are located in the center of the Yangtze River Delta - Jincheng Town, Jintan District, Changzhou City, Jiangsu Province. In addition to the production base located in the headquarters of Jintan District, Changzhou, Jiangsu, the company also has a production base in Huai'an Industrial Park, Jiangsu (a wholly-owned subsidiary Jiangsu willing bio-tech limited company www.willingbio.com ), covers an area of 200,000 square meters, more than 400 employees.

The company has the first-class administration and strong research and development team. It has established "Jiangsu Province Biological Veterinary Medicine Project Technical Centre." In 2007, the company passed the GMP certification of the national veterinary drug industry, and obtained the GMP certificate and veterinary drug production license. Up to now, the company has 4 major products passed the FDA certification, which is in the forefront of the industry. The main products are totriazuril, decoquinate, fipronil, teramycin, tulathromycin, doramectin, selamectin, milbemycin oxime and other high-end APIs and pharmaceutical intermediates.

The company adheres to the enterprise purpose of "making conscience medicine and doing rest assured medicine". Products are mainly sold to Europe, the United States and Southeast Asia and other places, has become the United States Loby Chemical, Germany Bayer, KRKA, Germany Boehringer Ingelheim, Ireland BIMEDA Pharmaceutical Group and other multinational companies strategic partners, the market and customers are highly recognized and praised.